Suramin-Induced Neurotoxicity: Preclinical Models and Neuroprotective Strategies
Suramin-Induced Neurotoxicity: Preclinical Models and Neuroprotective Strategies
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Suramin is a trypan blue analogon originally developed to treat protozoan infections, which was found to have diverse antitumor effects. One of the most severe side effects in clinical trials was the development of a peripheral sensory-motor polyneuropathy. In this study, we aimed to investigate suramin-induced neuropathy with a focus on calcium (C...
Alternative Titles
Full title
Suramin-Induced Neurotoxicity: Preclinical Models and Neuroprotective Strategies
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_8436afa68770459ea275a50ccc2a3eab
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8436afa68770459ea275a50ccc2a3eab
Other Identifiers
ISSN
1420-3049
E-ISSN
1420-3049
DOI
10.3390/molecules23020346
